BIOMAT Database Logo BIOMAT Database Logo

Trade names or approved names. Point II. Points of view. The clinical pharmacologist. 1974

P Turner

UI MeSH Term Description Entries
D009626 Terminology as Topic Works about the terms, expressions, designations, or symbols used in a particular science, discipline, or specialized subject area. Etymology,Nomenclature as Topic,Etymologies
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D010600 Pharmacology The study of the origin, nature, properties, and actions of drugs and their effects on living organisms. Pharmacologies
D012106 Research Critical and exhaustive investigation or experimentation, having for its aim the discovery of new facts and their correct interpretation, the revision of accepted conclusions, theories, or laws in the light of newly discovered facts, or the practical application of such new or revised conclusions, theories, or laws. (Webster, 3d ed) Research Priorities,Laboratory Research,Research Activities,Research and Development,Activities, Research,Activity, Research,Development and Research,Priorities, Research,Priority, Research,Research Activity,Research Priority,Research, Laboratory
D004339 Drug Compounding The preparation, mixing, and assembly of a drug. (From Remington, The Science and Practice of Pharmacy, 19th ed, p1814). Drug Formulation,Drug Preparation,Drug Microencapsulation,Pharmaceutical Formulation,Compounding, Drug,Formulation, Drug,Formulation, Pharmaceutical,Microencapsulation, Drug,Preparation, Drug
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004501 Education, Medical Use for general articles concerning medical education. Medical Education
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D001702 Biopharmaceutics The study of the physical and chemical properties of a drug and its dosage form as related to the onset, duration, and intensity of its action. Pharmaceutics,Pharmaceutic
D013607 Tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed) Tablet

Related Publications

P Turner
Trade names or approved names. Part II. Points of view. Europe.
February 1974, Postgraduate medical journal,
P Turner
Trade names or approved names. Part II. Points of view. The nurse.
February 1974, Postgraduate medical journal,
P Turner
Trade names or approved names. Part II. Points of view. The pharmaceutical company.
February 1974, Postgraduate medical journal,
P Turner
Trade names or approved names. Part II. Points of view. The retail pharmacist.
February 1974, Postgraduate medical journal,
P Turner
Trade names or approved names. Part II. Points of view. The hospital pharmacist.
February 1974, Postgraduate medical journal,
P Turner
Trade names or approved names. Part II. Points of view. The department of health.
February 1974, Postgraduate medical journal,
P Turner
Trade names or approved names. Part 11. Points of view. The general practitioner.
February 1974, Postgraduate medical journal,
P Turner
Trade names or approved names. Part III. Special cases. Clinical trials.
February 1974, Postgraduate medical journal,
P Turner
Trade names or approved names. Part IV. The solution. Introduction.
February 1974, Postgraduate medical journal,
P Turner
Trade names or approved names. Part III. Special cases. Antibiotics.
February 1974, Postgraduate medical journal,
Copied contents to your clipboard!